Figure 3. Forced SNHG22 expression correlates with chemoresistance in EOC patients. (A) A total of 40 patients were divided into SNHG22low and SNHG22high groups. The diagram shows the SNHG22 expression of each group. (B) Comparison of OS curves for patients with high and low SNHG22 expression that were treated with cisplatin or paclitaxel.